APPLICATION
ANDA070917
TYPE
ANDA
ORIGINAL APPROVAL
1989-02-03
LATEST ACTION
1996-04-26
ROUTE
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
NALBUPHINE HYDROCHLORIDEDiscontinued
NALBUPHINE HYDROCHLORIDE 20MG/ML (20MG/ML) · SOLUTION · INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Approval history
1996-04-26Labeling · Supplement 3AP
1991-02-28Labeling · Supplement 2AP
1990-07-25Labeling · Supplement 1AP
1989-02-03OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.